In the latest trading session, Amgen (AMGN) closed at $344.55, marking a -1.17% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.8% for the day. On the ...

We recently compiled a list of the 10 Most Undervalued Dow Stocks to Buy Now. Amgen Inc. is one of the most undervalued ...

Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

In addition to Bernstein, Amgen also received a Hold from Barclays’s Emily Field in a report issued today. However, on April 15, Bank of America Securities reiterated a Sell rating on Amgen (NASDAQ: ...

Fintel reports that on April 21, 2026, Canaccord Genuity initiated coverage of Amgen (NasdaqGS:AMGN) with a Hold ...

Amgen (AMGN) stock climbs as MariTide GLP-1 trials demonstrate nearly 20% weight loss. Truist raises price target to $325 amid growing optimism.

Amgen ( (AMGN)) has issued an update. On April 22, 2026, Amgen announced that David M. Reese, M.D., executive vice president and chief technology officer, will retire effective June 30, 2026, after a ...

This morning a "Potential Dividend Run Alert" went out for Amgen Inc (NASD: AMGN), at our DividendChannel.com Dividend Alerts service (a free email alerts feature). Let's look at the situation in ...

Amgen Inc. AMGN announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (“CHMP”) has rendered a positive opinion on, and has recommended conditional marketing ...